The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

9 Nov 2015 07:00

RNS Number : 9447E
Falanx Group Limited
09 November 2015
 

9 November 2015

 

FALANX GROUP LIMITED

("FALANX" or the "Company")

 

INTERIM RESULTS AND

UNAUDITED FINANCIAL STATEMENTS

FOR THE SIX MONTHS PERIOD ENDED 30 SEPTEMBER 2015

 

Falanx Group Limited, an intelligence, security and cyber defence provider working with blue chip and government clients worldwide, is pleased to announce its interim results for the six months ended 30 September 2015. 

 

Highlights

 

· Continued investment in cyber security capability, positioning the Group to capitalise on growing corporate requirement for protection from cyber-attacks.

· Placing in May 2015 of £2.49m

- £500,000 to extend the global licence agreement with Assuria to 16 April 2018 and development of the Falanx and Assuria Cloud partnership; and

- £2.14 million for the continued sales and marketing development of Falanx's cloud-based cyber security managed services

· Cash balance of £1.2m at 30 September 2015

· Agreements in place to become preferred cyber security provider to three regulated financial services companies

- Achieved ISO/IEC 20000-1, ISO/IEC 27001 and ISO 9001 accreditation

- Five new corporate intelligence contracts signed

· Strong Cyber pipeline

 

Post-period highlights

 

· New contract wins with several UK Government departments and corporate customers

 

John Blamire, CEO of Falanx Group, commented:

 

"During the period we have invested significantly in our cyber security capabilities, as we position ourselves to be first-movers in an industry that is increasingly in the public eye and the response of our customers is coming under increasing scrutiny. We are confident that we are reaching an inflection point, demonstrated by our recent contract wins, as businesses begin to prioritise the need for investment in protection from the well documented threat that cyber presents."

 

Enquiries:

 

Falanx Group Limited

John Blamire, Chief Executive

www.falanxgroup.com

www.falanxassuria.com

+ 44 (0) 20 7856 9457

 

 

 

Panmure Gordon (UK) Limited

Nominated Adviser & Broker

+44 (0) 207 886 2500

Mark Taylor

 

 

 

Redleaf Communications

Charlie Geller

Susie Hudson

 

+44 (0) 207 382 4730 

falanx@redleafpr.com 

 

Notes to Editors:

 

About Falanx Group

 

§ Falanx Group Limited is a global intelligence, security and cyber defence provider working with blue chip and government clients.

 

§ The Group has three business divisions:

 Falanx Intelligence: Political & Security Risk and Business Intelligence services

 Falanx Resilience: Security Consultancy, Crisis Management and asset and facility security

 Falanx Cyber: Comprehensive cloud-based cyber security services

 

§ The Group listed on AIM in June 2013 under ticker FLX.

 

§ For more information: http://www.falanxgroup.com/

 

 

 

CHAIRMAN'S STATEMENT

 

These results reflect the continuing investment in the development of our cyber security capability against a backdrop of increasing awareness of the threat posed to large corporate customers and government organisations from cyber-attack.

 

Widely publicised attacks in recent weeks against large consumer focused companies have highlighted the risks not only of financial loss resulting from data theft, but also the reputational damage suffered when customers' private information is lost. However, as with any industry which is evolving rapidly it will take time for large corporate customers and Government departments to properly assess the precise nature of the threat and identify their vulnerabilities. The cyber security industry is also likely to experience a period of rapid change with a number of small specialists being consolidated into a small number of large players. Falanx intends to be a leading niche player in this consolidation.

 

Results

Turnover for the six months ended 30 September 2015 was £792,430 (2014: £971,306) with Falanx Intelligence's revenue slightly lower at £766,037 (2014: £815,190). The loss before taxation increased to £1,309,437 (2014: £708,997) largely reflecting the increased investment of £1,340,253 in the development of our capability in Falanx Assuria.

 

The Group's cash balance at 30 September 2015 was £1.2 million (2014: £1.3 million).

 

Falanx Cyber

Falanx Cyber, operating under the Falanx Assuria brand, formally launched its Cyber Defence managed service nine months ago and its C-SOC is now fully operational. We are developing a unique capability to help clients combat a wide range of threats, and we are now well placed to support major organisations having secured the UK Government CERT programme last year. Contract negotiations with a number of prospects including those in the financial services industry continue. The lead time for securing large corporate and Government sales can be significant. Nonetheless, we are confident that the work undertaken during this period will result in concrete sales in the second half of the company's financial year.

 

Falanx Intelligence

Our Intelligence Division, trading as Stirling Assynt, continues to successfully serve its global customer base on a range of political and security risk issues in an environment where these are of increasing concern for large corporates. Sales were marginally lower during the period but management of costs resulted in an increase in operating profits in this division to £93,432 (2014: £86,368).

 

Falanx Resilience

We continue to investigate opportunities with partners and to seek to benefit from our contacts in the Gulf region.

 

Current Trading

Post the interims period, a number of contracts have been signed with UK Government departments and corporate customers. We are confident that this improved momentum will continue in the second half of the financial year.

 

Board Changes

As previously announced, I have decided to retire at the end of March 2016 after over two years as Chairman of Falanx as a public company on AIM and forty eight years since I joined the British Army. I will assist with the identification of a successor, and will remain as a consultant to the Company remaining involved with a number of specific projects which are currently under development.

 

The Board believes that Falanx has a significant opportunity to establish itself as a niche player in a consolidated cyber security industry, and during the period we have investigated a number of potential acquisitions. The business has a growing pipeline of business opportunities and we continue to pursue a number of UK and overseas opportunities which are at various stages of development.

 

 

K P A Barclay

Chairman

 

 

 

 

 

FALANX GROUP LIMITED

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS PERIOD ENDED 30 SEPTEMBER 2015

 

 

 

6 Months to

 

 

6 Months to

 

Year to

 

 

30 Sep 2015

 

30 Sep 2014

 

31 Mar 2015

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

£

 

£

 

£

Continuing operations

 

 

 

 

 

 

Revenue

 

792,430

 

971,306

 

1,922,049

Cost of sales

 

(858,032)

 

(777,015)

 

(1,811,324)

 

 

(65,602)

 

194,291

 

110,725

 

 

 

 

 

 

 

Administrative expenses

 

(1,236,118)

 

(903,560)

 

(2,223,897)

Exceptional item

 

-

 

-

 

(92,626)

Operating Profit/(Loss)

 

(1,301,720)

 

(709,269)

 

(2,205,798)

 

 

 

 

 

 

 

Finance income

 

283

 

272

 

525

Finance expense

 

(8,000)

 

-

 

-

Net finance expense

 

(7,717)

 

272

 

525

Profit/(Loss) before income tax

 

(1,309,437)

 

(708,997)

 

(2,205,273)

Income tax expense

 

-

 

-

 

(217,855)

Profit/(Loss) for the period from continuing operations

 

(1,309,437)

 

(708,997)

 

(2,423,128)

 

 

 

 

 

 

 

Gains on foreign subsidiary translation

 

-

 

3,337

 

-

Total comprehensive loss for the period

 

(1,309,437)

 

(705,660)

 

(2,423,128)

 

 

 

 

 

 

 

Earnings per share

 

 

 

 

 

 

Basic earnings per share - continuing and total operations

 

(1.95)p

 

(1.41)p

 

(4.75)p

Diluted earnings per share - continuing and total operations

 

(1.95)p

 

(1.41)p

 

(4.75)p

 

 

 

 

 

 

 

 

 

 

 

 

 

FALANX GROUP LIMITED

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 SEPTEMBER 2015

 

 

6 Months to

 

6 Months to

 

Year to

 

30 Sep 2015

 

30 Sep 2014

 

31 Mar 2015

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

 

 

 

 

£

 

£

 

£

Assets

 

 

 

 

 

Non-current assets

 

 

 

 

 

Property, plant & equipment

69,821

 

14,524

 

69,964

Intangible assets

227,874

 

401,880

 

300,167

Deferred tax

-

 

203,862

 

-

 

297,695

 

620,266

 

370,131

Current assets

 

 

 

 

 

Inventory

56,044

 

33,075

 

56,977

Trade and other receivables

907,215

 

612,564

 

660,159

Cash and cash equivalents

1,211,914

 

1,320,850

 

428,084

 

2,175,173

 

1,966,489

 

1,145,220

 

 

 

 

 

 

Total assets

2,472,868

 

2,586,755

 

1,515,351

 

 

 

 

 

 

Equity

 

 

 

 

 

Capital and reserves attributable to equity holders of the Company

 

 

 

 

 

Share premium account

5,289,771

 

2,537,631

 

2,841,797

Translation reserve

(18,139)

 

3,338

 

(29,224)

Shares to be issued reserve

91,875

 

-

 

91,875

Retained earnings

(3,678,051)

 

(654,483)

 

(2,368,614)

Total equity

1,685,456

 

1,886,485

 

535,834

 

 

 

 

 

 

Liabilities

 

 

 

 

 

Current liabilities

 

 

 

 

 

Trade and other payables

773,419

 

700,270

 

965,524

Deferred tax liability

13,993

 

-

 

13,993

 

787,412

 

700,270

 

979,517

 

 

 

 

 

 

Total liabilities

787,412

 

700,270

 

979,517

 

 

 

 

 

 

Total equity and liabilities

2,472,868

 

2,586,755

 

1,515,351

 

 

 

 

 

 

 

 

 

 

 

FALANX GROUP LIMITED

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

Share premium

Retained earnings

Translation reserve

Shares to be issued reserve

Total

 

£

£

£

 

£

 

 

 

 

 

 

Balance at 1 April 2014

540,964

54,514

-

-

595,478

 

Loss for year

-

(2,423,128)

-

-

(2,423,128)

Transactions with owners:

 

 

 

 

 

Issue of share capital

2,368,333

 

-

-

-

2,368,333

Cost of share capital issue

(67,500)

 

-

-

-

(67,500)

Translation of foreign subsidiary

-

-

(29,224)

-

(29,224)

Share options issued

-

-

-

91,875

91,875

 

 

 

 

 

 

Balance as at 31 March 2015

2,841,797

(2,368,614)

(29,224)

91,875

535,834

 

Loss for the period

 

-

(1,309,437)

-

 

 

Transactions with owners:

 

 

 

 

 

Issue of share capital

2,642,999

 

-

-

-

2,649,874

Costs of issue of share capital

(195,025)

 

-

-

-

(201,990)

Translation of foreign subsidiary

-

-

11,085

-

11,085

 

 

 

 

 

 

Balance as at 30 September 2015

5,289,771

(3,678,051)

(18,139)

91,875

1,685,456

 

 

 

 

 

 

FALANX GROUP LIMITED

 

CONSOLIDATED CASH FLOW STATEMENT FOR THE PERIOD ENDED 30 SEPTEMBER 2015

 

 

 

6 Months to

6 Months to

 

Year to

 

30 Sep 2015

30 Sep 2014

 

31 Mar 2015

 

(Unaudited)

(Unaudited)

 

(Audited)

 

£

£

 

£

Cash flows from operating activities

 

 

 

 

Profit/(Loss) before tax

(1,309,437)

(708,997)

 

(2,205,273)

Adjustments for:

 

 

 

 

Depreciation

10,984

3,159

 

8,862

Amortisation of intangibles

72,293

70,410

 

141,134

Share based payment

-

-

 

91,875

Loss on disposal of equipment/fixtures & fittings

-

-

 

183

Foreign exchange loss

-

3,345

 

-

Net finance expense/(income) recognised in profit or loss

7,717

(272)

 

(525)

 

(1,218,443)

(632,355)

 

(1,963,744)

Changes in working capital:

 

 

 

 

Decrease in inventories

933

-

 

(23,902)

(Increase)/Decrease in trade and other receivables

(247,056)

647,742

 

600,148

Decrease in trade and other payables

(192,105)

(450,942)

 

(185,692)

Cash used in operations

(1,656,671)

(435,555)

 

(1,573,190)

 

Interest paid

(8,000)

-

 

-

Net cash used in operating activities

(1,664,671)

(435,555)

 

(1,573,190)

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

Interest received

283

272

 

525

Acquisition of equipment/fixtures and fittings

(10,841)

(8,658)

 

(69,923)

Acquisition of intangibles

-

(442,290)

 

(411,301)

Net cash from investing activities

(10,558)

(450,676)

 

(480,699)

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Net Proceeds from issue of shares

2,447,974

1,996,667

 

2,300,833

Net cash used in financing activities

2,447,974

1,996,667

 

2,300,833

 

 

 

 

 

Increase/(decrease) in cash equivalents

772,745

1,110,436

 

246,944

Cash and cash equivalents at beginning of the period

428,084

210,414

 

210,414

Foreign exchange losses on cash and cash equivalents

11,085

-

 

(29,274)

Cash and cash equivalents at end of the period

1,211,914

1,320,850

 

428,084

 

 

 

 

 

 

 

 

 

 

 

 

 

FALANX GROUP LIMITED

 

NOTES TO INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 SEPTEMBER 2014

 

 

 

1. General information

 

Falanx (the "Company") and its subsidiaries (together the "Group") operate in the security and intelligence markets.

The Company is a public limited company which is listed on AIM on the London Stock Exchange and is incorporated and domiciled in the British Virgin Islands. The address of its registered office is PO Box 173, Road Town, Tortola, British Virgin Islands.

 

 

2. Basis of preparation

 

These interim statements have been prepared on a basis consistent with International Financial Reporting Standards (IFRS). They do not contain all of the information required for full financial statements and should be read in conjunction with the consolidated financial statements of the Group as at and for the year ended 31 March 2015. These interim financial statements do not constitute statutory accounts within the meaning of the Companies Act.

 

The interim financial information have not been reviewed nor audited by the auditors. The interim financial information was approved by the Board of Directors on 9 November 2015. The information for the year ended 31 March 2015 is extracted from the statutory financial statements for that year which have been reported on by the Group's auditors and delivered to the Registrar of Companies. The audit report was unqualified.

 

The accounting policies applied by the Group in these interim financial statements are the same as those applied by the Group in its consolidated financial statements for the year ended and as at 31 March 2015. The interim report is the responsibility of, and has been, approved by the Directors. The Directors are responsible for preparing the interim financial statements in accordance with the AIM rules for Companies.

 

 

3. Critical accounting estimates and judgements

 

The preparation of financial information in accordance with generally accepted accounting practice, in the case of the Group being IFRS as adopted by the European Union, requires the Directors to make estimates and judgements that affect the reported amount of assets, liabilities, income and expenditure and the disclosures made in the financial statements. Such estimates and judgements must be continually evaluated based on historical experience and other factors, including expectations of future events.

The significant judgements made by management in applying the Group's accounting policies were the same as those applied in the last annual financial statements for the year ended 31 March 2015.

 

 

4. Segmental reporting

 

The Directors consider that the Group's internal financial reporting is organised along product and service lines and, therefore, segmental information has been presented about business segments. The segmental analysis of the Group's business was derived from its principal activities as set out below. The information below also comprises the disclosures required by IFRS 8 in respect of products and services as the Directors consider that the products and services sold by the disclosed segments are essentially similar and, therefore, no additional disclosure in respect of products and services is required. The other segment below and overleaf is made up of the parent company's administrative operation.

 

Reportable segments

The reportable segment results for the year ended 30 September 2015 are as follows:

 

 

 

 

Other

 

 

Intelligence

Resilience

Cyber

 segments

Total

 

£

£

£

£

£

Revenues from external customers

766,037

-

26,393

-

792,430

Total revenue

766,037

-

26,393

-

792,430

Operating expenses

(666,702)

(25)

(876,996)

(467,150)

(2,010,873)

Finance costs - net

15

-

-

(7,732)

(7,717)

Depreciation and amortisation

(5,918)

-

(77,359)

-

(83,277)

Segment profit/(loss) for the year

93,432

(25)

(927,962)

(474,882)

(1,309,437)

 

The reportable segment results for the year ended 30 September 2014 are as follows:

 

 

 

 

Other

 

 

Intelligence

Resilience

Cyber

 segments

Total

 

£

£

£

£

£

Revenues from external customers

815,190

156,116

-

-

971,306

Total revenue

815,190

156,116

-

-

971,306

Operating expenses

(722,560)

(186,673)

(301,619)

(492,817)

(1,603,669)

Finance cost - net

177

-

-

95

272

Depreciation and amortisation

(6,439)

-

(67,130)

-

(73,569)

Segment profit/(loss) for the year

86,368

(30,557)

(268,749)

(492,722)

(705,660)

 

Segment assets and liabilities as at 30 September 2015 and capital expenditure for the year then ended are as follows:

 

 

 

 

Other

 

 

Intelligence

Resilience

Cyber

 segments

Total

 

£

£

£

£

£

Total assets

806,209

40

880,006

786,612

2,472,867

Liabilities

462,175

151,007

112,819

61,411

787,412

Capital expenditure

3,947

-

6,894

-

10,841

 

Segment assets and liabilities as at 30 September 2014 and capital expenditure for the year then ended are as follows:

 

 

 

 

Other

 

 

Intelligence

Resilience

Cyber

 segments

Total

 

£

£

£

£

£

Total assets

1,377,298

107,741

423,521

678,195

2,586,755

Liabilities

408,079

151,002

22,721

128,468

700,270

Capital expenditure

1,146

-

449,803

-

450,949

 

 

5. Earnings per share

Basic earnings per share is calculated by dividing the profit attributable to equity holders of the Company by the weighted average number of ordinary shares in issue during the year.

 

 

6 Months to

6 Months to

Year to

 

30 Sep 2015

30 Sep 2014

31 Mar 2015

 

(Unaudited)

(Unaudited)

(Audited)

 

 

 

 

Loss attributable to equity holders of the company (£)

(1,309,437)

(705,660)

(2,423,128)

Weighted average number of ordinary shares in issue

67,238,391

50,152,595

50,992,482

Basic (loss)/profit per share (pence per share)

(1.95)

(1.40)

(4.75)

 

As at 30 September 2015, the potentially dilutive ordinary shares were anti-dilutive because the Group was loss-making.

 

6. Related party transactions

Payment for services

From 1 April 2014 to 30 September 2015 Andrea Barclay, the partner of K P A Barclay, Executive Chairman was paid £7,150 (2013: £2,750) in respect of research and report writing for the 100% owned subsidiary Stirling Assynt (Europe) Limited.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LVLLBEFFLFBD
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.